A study on combination of non-ablative local RFA with PD-1 and angiogenesis blocking to prolong survival through improvement of immune microenvironment in advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A study on combination of non-ablative local RFA with PD-1 and angiogenesis blocking to prolong survival through improvement of immune microenvironment in advanced Hepatocellular Carcinoma

Published:2024-06 Issue: Volume:134 Page:112144
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Xiao Tianlin,Hu Sheng,Dong Shuang,Cai Qian,Gong Wei,Zhang Yang,Long Cheng,Li Xiaoyu^ORCID

Funder

Wuhan Science and Technology Bureau

Department of Science and Technology of Hubei Province

Health Commission of Hubei Province

Ministry of Science and Technology of the People's Republic of China

Publisher

Elsevier BV

Reference40 articles.

1. w.b.e. Cancer Genome Atlas Research Network. Electronic address, N. Cancer Genome Atlas Research, Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell 169(7) (2017) 1327-1341 e23.

2. Changing epidemiology of hepatocellular carcinoma in Asia;Zhang;Liver Int,2022

3. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma;Johnson;Nat Rev Gastroenterol Hepatol,2022

4. Evolving therapeutic landscape of advanced hepatocellular carcinoma;Yang;Nat Rev Gastroenterol Hepatol,2023

5. Targeted therapy for hepatocellular carcinoma;Huang;Signal Transduct Target Ther,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP